Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Manhattan Eye, Ear & Throat Hospital Alcon Research |
---|---|
Information provided by: | Manhattan Eye, Ear & Throat Hospital |
ClinicalTrials.gov Identifier: | NCT00211419 |
The purpose of this study is to evaluate the safety of combining juxtasclerally administered anecortave acetate 15 mg with triamcinolone acetate 4 mg administered intravitreally following photodynamic therapy with verteporfin for the treatment of exudative age-related macular degeneration (AMD).
Condition | Intervention | Phase |
---|---|---|
Maculopathy, Age-Related |
Drug: Anecortave Acetate 15 mg Drug: Triamcinolone Acetate 4 mg Procedure: Photodynamic Therapy with Verteporfin Procedure: Thermal Laser |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control |
Official Title: | Pilot Study of the Combination of Anecortave Acetate 15mg Delivered by Posterior Juxtascleral Injection and Triamcinolone Acetonide 4mg Delivered by Intravitreal Injection for the Treatment of Exudative Age-Related Macular Degeneration (AMD) |
Ages Eligible for Study: | 50 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, New York | |
Manhattan Eye, Ear & Throat Hospital | |
New York, New York, United States, 10021 | |
Vitreous-Retina-Macula Consultants of NY | |
New York, New York, United States, 10022 |
Principal Investigator: | Jason S Slakter, MD | Manhattan Eye, Ear & Throat Hospital |
Study ID Numbers: | Double Injection |
Study First Received: | September 13, 2005 |
Last Updated: | February 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00211419 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Exudative Age-Related Macular Degeneration AMD |
Anti-Inflammatory Agents Immunologic Factors Hormone Antagonists Eye Diseases Verteporfin Hormones, Hormone Substitutes, and Hormone Antagonists Macular Degeneration Retinal Degeneration Triamcinolone diacetate |
Immunosuppressive Agents Glucocorticoids Hormones Triamcinolone hexacetonide Photosensitizing Agents Triamcinolone Acetonide Radiation-Sensitizing Agents Triamcinolone Retinal Diseases |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Immunologic Factors Eye Diseases Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Verteporfin Macular Degeneration Retinal Degeneration Enzyme Inhibitors Triamcinolone diacetate Immunosuppressive Agents |
Hormones Glucocorticoids Pharmacologic Actions Triamcinolone hexacetonide Photosensitizing Agents Triamcinolone Acetonide Radiation-Sensitizing Agents Therapeutic Uses Triamcinolone Dermatologic Agents Retinal Diseases |